Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2025

Jan 30, 2025

33819_dirs_2025-01-30_b2dffb1f-349a-4ad5-9cc4-3d2181031025.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2025-01-28

Reporting Person: Madden Martin J. (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-01-28 Stock Option (Right to Buy) $1.93 A 10000 Acquired 2035-01-28 Common Stock, par value $0.01 per share (10000) Direct